Manual on the proper use of lutetium-177-labeled somatostatin analogue (Lu-177-DOTA-TATE) injectable in radionuclide therapy (2nd ed.)
2018 · Annals of Nuclear Medicine · 64 citations
https://doi.org/10.1007/s12149-018-1230-7
H
Hideharu Ikebuchi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
85
Papers
767
Citations
17
h-index
30
i10-index
Hideharu Ikebuchi is an academic researcher from Uppsala University. The author has contributed to research in topics: Mycotoxins in Agriculture and Food & Protein Kinase Regulation and GTPase Signaling & Growth Hormone and Insulin-like Growth Factors. The author has an h-index of 17, co-authored 73 publications.
Papers by this author
worksEffect of an ectokinase inhibitor, K252b, on degranulation and Ca2+ signals of RBL-2H3 cells and human basophils
1997 · The Journal of Immunology · 19 citations
https://doi.org/10.4049/jimmunol.159.2.964
Manual on the proper use of yttrium-90-labeled anti-P-cadherin antibody injection for radionuclide therapy in clinical trials
2019 · Annals of Nuclear Medicine · 3 citations
https://doi.org/10.1007/s12149-019-01409-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat